Aurinia Pharmaceuticals Inc (AUPH) is a publicly traded Healthcare sector company. As of May 19, 2026, AUPH trades at $15.65 with a market cap of $1.97B and a P/E ratio of 6.86. AUPH moved +0.51% today. Year to date, AUPH is +1.63%; over the trailing twelve months it is +90.48%. Its 52-week range spans $6.55 to $16.88. Analyst consensus is buy with an average price target of $16.00. Rallies surfaces AUPH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading AUPH stock inside the company?
Recent AUPH insider activity includes TANG KEVIN bought 184.21K, TANG KEVIN bought 83.56K, TANG KEVIN bought 115.79K, TANG KEVIN bought 300.00K, and TANG KEVIN bought 214.84K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
AUPH Key Metrics
Key financial metrics for AUPH
Metric
Value
Price
$15.65
Market Cap
$1.97B
P/E Ratio
6.86
EPS
$2.26
Dividend Yield
0.00%
52-Week High
$16.88
52-Week Low
$6.55
Volume
323.13K
Avg Volume
0
Revenue (TTM)
$298.30M
Net Income
$298.21M
Gross Margin
89.74%
Recent AUPH Insider Trades
TANG KEVIN bought 184.21K (~$2.62M) on Mar 3, 2026.
TANG KEVIN bought 83.56K (~$1.20M) on Mar 2, 2026.
TANG KEVIN bought 115.79K (~$1.65M) on Mar 2, 2026.
TANG KEVIN bought 300.00K (~$4.17M) on Feb 27, 2026.
TANG KEVIN bought 214.84K (~$3.03M) on Feb 27, 2026.
Recent AUPH insider activity includes TANG KEVIN bought 184.21K, TANG KEVIN bought 83.56K, TANG KEVIN bought 115.79K, TANG KEVIN bought 300.00K, and TANG KEVIN bought 214.84K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for AUPH?
Yes. Rallies tracks AUPH insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is AUPH research on Rallies investment advice?
No. Rallies provides research, data, and educational context for AUPH. It does not provide personalized investment advice.
